Advertisement
BRKR vs MTD
Which Stock Would AI Choose? Bruker Corporation (BRKR) vs. Mettler-Toledo International Inc. (MTD) Stock Comparison
Key Takeaways
- MTD has outperformed BRKR over the past year with approximately 15% total return compared to BRKR's -9% decline.
- Both companies operate in the precision scientific instruments sector, serving life sciences and industrial markets, but MTD exhibits greater price stability with a 52-week range of $1,052 to $1,525 versus BRKR's wider $28.53 to $56.22 swing.
- Recent market activity shows BRKR trading around the mid-$30s amid volatility, influenced by new product announcements, while MTD holds near $1,270 ahead of Q1 earnings.
- Tickeron's AI tools highlight sector momentum in related areas like semiconductors and industrials, potentially benefiting both stocks' growth drivers.
- MTD's larger market capitalization provides a buffer against volatility compared to BRKR's more pronounced fluctuations.
Introduction
Bruker Corporation (BRKR) and Mettler-Toledo International Inc. (MTD) are key players in the precision scientific instruments sector, providing essential tools for life sciences, pharmaceuticals, and industrial applications. This stock comparison analyzes their recent performance, business models, and market positioning to help traders and investors gauge relative strengths in the current environment. Amid broader market volatility and sector-specific catalysts like earnings reports and product innovations, value-oriented investors and technical traders may find insights into momentum, risk, and growth potential. Understanding these dynamics supports informed decisions on stock comparison and relative performance.
BRKR Overview and Recent Performance
Bruker Corporation (BRKR) develops scientific instruments and solutions for molecular and cellular analysis, including NMR (nuclear magnetic resonance), mass spectrometry, and microscopy systems used in pharmaceuticals, biotechnology, and academia. In recent market activity, BRKR shares have traded in the mid-$30s to low-$40s, reflecting volatility with a 52-week range from $28.53 to $56.22. Sentiment has been influenced by product launches, such as new NMR workflow solutions announced in recent weeks, which drove a temporary 4% share price increase. Broader pressures from sector slowdowns in life sciences have contributed to a yearly decline of about 9%, though upcoming Q1 2026 earnings could provide catalysts for recovery.
MTD Overview and Recent Performance
Mettler-Toledo International Inc. (MTD) is a global leader in precision instruments and services, offering laboratory balances, pipettes, analytical sensors, and industrial weighing solutions for pharma, food, and chemical industries. Shares have maintained stability around $1,270 in recent weeks, within a 52-week range of $1,052 to $1,525, supported by steady demand. Performance reflects a positive yearly gain of roughly 15%, bolstered by resilient end-markets despite mixed analyst views ahead of Q1 2026 earnings, where EPS growth of 6.2% is anticipated. Recent price adjustments have been modest, driven by broader economic factors rather than company-specific setbacks.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases the top 25 AI trading bots curated from over 351 available bots that trade thousands of tickers across stocks, ETFs, and crypto. These bots earn their trending status through AI-driven analysis suited to current market conditions like volatility in semiconductors, industrials, and data centers. Performance stats vary: annualized returns range from +37% to +162%, with win rates of 51% to 88% (e.g., +83% return at 68% win rate for semiconductors; +94% for industrials). Strategies include trend following, scalping with take-profit/stop-loss (TP/SL) corridors like 3%/2%, and fundamental analysis across timeframes from 5 minutes to 60 minutes. Traders can copy these bots for real-time signals with risk management. Explore the page to match bots to your style.
Head-to-Head Comparison
Both BRKR and MTD focus on precision instruments but differ in emphasis: BRKR leans toward advanced imaging and spectroscopy for R&D, while MTD prioritizes everyday lab essentials like balances and automation. Growth drivers include life sciences demand for BRKR and industrial diversification for MTD. Recent momentum favors MTD's steadier uptrend versus BRKR's volatility. Risk factors: BRKR faces higher beta (1.20, a measure of market sensitivity) and sector headwinds; MTD benefits from a larger ~$28B market cap for resilience. Sector exposure overlaps in healthcare equipment, but MTD shows stronger market sentiment via analyst targets implying 15% upside. Trade-offs highlight BRKR's potential for catalyst-driven rebounds against MTD's consistent positioning.
Tickeron AI Verdict
Tickeron’s AI currently favors MTD due to superior trend consistency, relative yearly outperformance, and stability amid upcoming earnings. BRKR offers rebound potential from recent innovations, but MTD's positioning suggests higher probability of sustained momentum in the near term, based on observable price action and sector trends.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRKR is a Hold and MTD is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BRKR’s FA Score shows that 1 FA rating(s) are green whileMTD’s FA Score has 1 green FA rating(s).
- BRKR’s FA Score: 1 green, 4 red.
- MTD’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BRKR’s TA Score shows that 6 TA indicator(s) are bullish while MTD’s TA Score has 4 bullish TA indicator(s).
- BRKR’s TA Score: 6 bullish, 4 bearish.
- MTD’s TA Score: 4 bullish, 6 bearish.
Price Growth
BRKR (@Medical/Nursing Services) experienced а +0.98% price change this week, while MTD (@Medical Specialties) price change was -21.02% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.28%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was -5.53%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +8.39%. For the same industry, the average monthly price growth was +2.49%, and the average quarterly price growth was -6.93%.
Reported Earning Dates
BRKR is expected to report earnings on Aug 05, 2026.
MTD is expected to report earnings on Jul 23, 2026.
Industries' Descriptions
@Medical/Nursing Services (-1.28% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Medical Specialties (+8.39% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| BRKR | MTD | BRKR / MTD | |
| Capitalization | 6.72B | 20.8B | 32% |
| EBITDA | 306M | 1.24B | 25% |
| Gain YTD | -6.121 | -25.268 | 24% |
| P/E Ratio | 74.88 | 24.23 | 309% |
| Revenue | 3.46B | 4.03B | 86% |
| Total Cash | 133M | 66.9M | 199% |
| Total Debt | 1.67B | 2.15B | 78% |
BRKR | MTD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 11 | 52 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 71 Overvalued | 99 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 91 | 3 | |
PRICE GROWTH RATING 1..100 | 45 | 65 | |
P/E GROWTH RATING 1..100 | 5 | 67 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BRKR's Valuation (71) in the Medical Specialties industry is in the same range as MTD (99). This means that BRKR’s stock grew similarly to MTD’s over the last 12 months.
BRKR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MTD (100). This means that BRKR’s stock grew similarly to MTD’s over the last 12 months.
MTD's SMR Rating (3) in the Medical Specialties industry is significantly better than the same rating for BRKR (91). This means that MTD’s stock grew significantly faster than BRKR’s over the last 12 months.
BRKR's Price Growth Rating (45) in the Medical Specialties industry is in the same range as MTD (65). This means that BRKR’s stock grew similarly to MTD’s over the last 12 months.
BRKR's P/E Growth Rating (5) in the Medical Specialties industry is somewhat better than the same rating for MTD (67). This means that BRKR’s stock grew somewhat faster than MTD’s over the last 12 months.
| BRKR | MTD | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 59% | 2 days ago 88% |
| Stochastic ODDS (%) | 2 days ago 81% | 2 days ago 66% |
| Momentum ODDS (%) | 2 days ago 76% | 2 days ago 56% |
| MACD ODDS (%) | 2 days ago 71% | 2 days ago 63% |
| TrendWeek ODDS (%) | 2 days ago 71% | 2 days ago 63% |
| TrendMonth ODDS (%) | 2 days ago 73% | 2 days ago 66% |
| Advances ODDS (%) | 8 days ago 69% | 10 days ago 63% |
| Declines ODDS (%) | 17 days ago 71% | 3 days ago 63% |
| BollingerBands ODDS (%) | 2 days ago 71% | 2 days ago 79% |
| Aroon ODDS (%) | 2 days ago 60% | 2 days ago 68% |
Advertisement
BRKR and
Correlation & Price change
A.I.dvisor indicates that over the last year, BRKR has been closely correlated with A. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if BRKR jumps, then A could also see price increases.
| Ticker / NAME | Correlation To BRKR | 1D Price Change % | ||
|---|---|---|---|---|
| BRKR | 100% | +0.71% | ||
| A - BRKR | 78% Closely correlated | +0.46% | ||
| MTD - BRKR | 75% Closely correlated | +1.60% | ||
| WAT - BRKR | 68% Closely correlated | -0.51% | ||
| RVTY - BRKR | 68% Closely correlated | +1.44% | ||
| TMO - BRKR | 66% Loosely correlated | +0.49% | ||
More | ||||
MTD and
Correlation & Price change
A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.
| Ticker / NAME | Correlation To MTD | 1D Price Change % | ||
|---|---|---|---|---|
| MTD | 100% | +1.60% | ||
| A - MTD | 75% Closely correlated | +0.46% | ||
| TMO - MTD | 70% Closely correlated | +0.49% | ||
| DHR - MTD | 68% Closely correlated | -0.87% | ||
| BRKR - MTD | 67% Closely correlated | +0.71% | ||
| AZTA - MTD | 61% Loosely correlated | -1.35% | ||
More | ||||